Thu. Oct 21st, 2021
From NewsMax

Pfizer Inc said on Monday it has started a mid-to-late-stage study testing its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have been exposed to the virus. The company and its rivals, including U.S.-based Merck & Co Inc and…
Read More

By

Leave a Reply

Your email address will not be published. Required fields are marked *